Product Description
Overall, the global vascular closure device (VCD) market was valued at $863 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach over $1 billion.
Throughout this medical market research, we analyzed over 15 VCD companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for VCDs extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global VCD Market Insights
A current trend in the VCD market is the move towards faster and less invasive closure methods. There is an increasing preference for devices enabling swift hemostasis, less patient discomfort, and quicker recovery. Manufacturers are emphasizing the creation of closure devices that reduce the reliance on manual pressure or sutures, aiming for enhanced patient experiences and potentially lowering complication risks. Technological advancements have led to devices offering improved control and accuracy during closure, contributing to the broader adoption of VCDs in various interventional procedures.
Global VCD Market Share Insights
- Abbott, the leading competitor, provides three invasive closure devices – StarClose™, PerClose ProGlide™, and ProStar™ XL. PerClose™ utilizes needles and a knot for arterial hole suturing, while StarClose™ features a nitinol clip for external closure to prevent emboli. ProStar™ XL is a suture-based device designed for closures at access sites between 8.5 F and 10 F.
- Terumo‘s strong position in the VCD market is driven by the success of the Angio-Seal™ product line. The Angio-Seal™ VIP, an enhanced version with features like a coated suture and collagen sponge, has contributed significantly. The Angio-Seal™ Evolution™, introduced in 2010, includes an automated deployment system to address procedural variables.
- Cardinal Health strengthened its VCD market presence with the 2015 Cordis acquisition. AccessClosure’s Mynx™ VCD, addressing challenges like vessel malpositioning, became part of Cardinal Health’s portfolio. The Mynx™ product line, now under Cardinal Health, includes Mynx™ACE® and MynxGrip® VCDs.
Market Segmentation Summary
- Invasive VCD Market
- Non-Invasive VCD Market
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.